TransPharma Medical Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.6M
TransPharma Medical General Information
Description
Developer of products utilizing transdermal drug delivery technology. The company's products include ViaDerm device, a transdermal drug delivery system that delivers peptide and protein therapeutics painlessly.
Contact Information
Website
www.transpharma-medical.comCorporate Office
- Second Yodfat street
- Northern Industrial Zone
- Lod 71291
- Israel
Corporate Office
- Second Yodfat street
- Northern Industrial Zone
- Lod 71291
- Israel
TransPharma Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 13-Mar-2012 | $3.6M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series C) | 24-Jul-2006 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 10-Jun-2003 | $8.9M | $15.4M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jul-2001 | $6.5M | $6.5M | Completed | Product Development |
TransPharma Medical Patents
TransPharma Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2011128902-A2 | Stiffener for use with a drug patch | Inactive | 15-Apr-2010 | ||
| WO-2011128902-A3 | Stiffener for use with a drug patch | Inactive | 15-Apr-2010 | ||
| ES-2461619-T3 | Electric skin rejuvenation | Active | 25-Feb-2009 | ||
| WO-2010097790-A1 | Electrical skin rejuvenation | Inactive | 25-Feb-2009 | ||
| WO-2010029552-A1 | Transdermal delivery of oligosaccharides | Inactive | 10-Sep-2008 | A61K9/0021 |
TransPharma Medical Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biomedical Investments | Venture Capital | Minority | ||
| Discount Capital | Asset Manager | Minority | ||
| Evergreen Venture Partners | Venture Capital | Minority | ||
| Pitango Venture Capital | Venture Capital | Minority | ||
| SCP Vitalife Partners | Venture Capital | Minority |
TransPharma Medical FAQs
-
When was TransPharma Medical founded?
TransPharma Medical was founded in 2000.
-
Where is TransPharma Medical headquartered?
TransPharma Medical is headquartered in Lod, Israel.
-
What industry is TransPharma Medical in?
TransPharma Medical’s primary industry is Drug Delivery.
-
Is TransPharma Medical a private or public company?
TransPharma Medical is a Private company.
-
What is the current valuation of TransPharma Medical?
The current valuation of TransPharma Medical is .
-
What is TransPharma Medical’s current revenue?
The current revenue for TransPharma Medical is .
-
How much funding has TransPharma Medical raised over time?
TransPharma Medical has raised $33.4M.
-
Who are TransPharma Medical’s investors?
Biomedical Investments, Discount Capital, Evergreen Venture Partners, Pitango Venture Capital, and SCP Vitalife Partners are 5 of 8 investors who have invested in TransPharma Medical.
-
When was TransPharma Medical acquired?
TransPharma Medical was acquired on 13-Mar-2012.
-
Who acquired TransPharma Medical?
TransPharma Medical was acquired by Candela Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process